Position in ZYBT
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$7,513
-$2,968 QoQ
Shares Held
8,036
-11.8% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 7 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZYBT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026UBS Group AG holds $1,523,036,852 across 81 Drug Manufacturers - Specialty & Generic names. ZYBT ranks #63 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
2,799,543 | $330,933,975 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
8,572,057 | $205,129,322 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
1,221,036 | $160,859,281 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
236,729 | $140,375,559 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
4,151,638 | $86,188,003 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,192,264 | $66,820,205 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
867,675 | $65,813,148 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,877,217 | $56,541,775 |
All Filings in ZYBT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,513 | 8,036 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $10,481 | 9,115 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $11,341 | 4,329 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $922,435 | 154,512 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,934 | 1,289 | Shares | Defined | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||